January 2017 FDA Recall Drug by Actavis Inc
D-0439-2017 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Actavis Inc on January 12, 2017 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0439-2017

Reason for Recall
Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Initiated
01-12-2017
Reported
02-01-2017
Quantity
164,844 units

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide in the US
Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories Inc., Corona, CA 92880 USA, Mfd. by Cipla Ltd. Verna, Goa India, NDC 0591-3467-53

Batch or Lot Expiration Information

Lot# : GA51265, Ex[p. Jan-2017, GA51454, GA51553, GA51583, Exp. Feb-2017, GA51598, GA51724, GA51725, GA51749, Exp. Mar-2017